4.7 Article

Removal of H2A.Z by INO80 promotes homologous recombination

期刊

EMBO REPORTS
卷 16, 期 8, 页码 986-994

出版社

WILEY
DOI: 10.15252/embr.201540330

关键词

ANP32E; chromatin; H2A.Z; homologous recombination; INO80

资金

  1. Cancer Research UK [C7905/A16417]
  2. Ministry of Higher Education-Saudi Arabia
  3. Cancer Research UK [16417] Funding Source: researchfish

向作者/读者索取更多资源

The mammalian INO80 remodelling complex facilitates homologous recombination (HR), but the mechanism by which it does this is unclear. Budding yeast INO80 can remove H2A.Z/H2B dimers from chromatin and replace them with H2A/H2B dimers. H2A.Z is actively incorporated at sites of damage in mammalian cells, raising the possibility that H2A.Z may need to be subsequently removed for resolution of repair. Here, we show that H2A.Z in human cells is indeed rapidly removed from chromatin flanking DNA damage by INO80. We also report that the histone chaperone ANP32E, which is implicated in removing H2AZ from chromatin, similarly promotes HR and appears to work on the same pathway as INO80 in these assays. Importantly, we demonstrate that the HR defect in cells depleted of INO80 or ANP32E can be rescued by H2A.Z co-depletion, suggesting that H2A.Z removal from chromatin is the primary function of INO80 and ANP32E in promoting homologous recombination.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Differential and longitudinal immune gene patterns associated with reprogrammed microenvironment and viral mimicry in response to neoadjuvant radiotherapy in rectal cancer

Anna Wilkins, Elisa Fontana, Gift Nyamundanda, Chanthirika Ragulan, Yatish Patil, David Mansfield, Jennifer Kingston, Fiona Errington-Mais, Daniel Bottomley, Katharina von Loga, Hannah Bye, Paul Carter, Emma Tinkler-Hundal, Amir Noshirwani, Jessica Downs, Magnus Dillon, Sandra Demaria, David Sebag-Montefiore, Kevin Harrington, Nick West, Alan Melcher, Anguraj Sadanandam

Summary: This study utilized immune gene expression profiling and a unique quantitative method for assessing tumor response to neoadjuvant therapy in rectal cancer patients. It revealed differences in tumor response and identified potential immune targets for therapy, offering insights for novel treatment strategies.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Article Oncology

PBRM1 Deficiency Confers Synthetic Lethality to DNA Repair Inhibitors in Cancer

Roman M. Chabanon, Daphne Morel, Thomas Eychenne, Leo Colmet-Daage, Ilirjana Bajrami, Nicolas Dorvault, Marlene Garrido, Cornelia Meisenberg, Andrew Lamb, Carine Ngo, Suzanna R. Hopkins, Theodoros Roumeliotis, Samuel Jouny, Clemence Henon, Asuka Kawai-Kawachi, Clemence Astier, Asha Konde, Elaine Del Nery, Christophe Massard, Stephen J. Pettitt, Raphael Margueron, Jyoti S. Choudhary, Genevieve Almouzni, Jean-Charles Soria, Eric Deutsch, Jessica A. Downs, Christopher J. Lord, Sophie Postel-Vinay

Summary: Inactivation of PBRM1 is common in cancer, including ccRCC. Studies show that PARP and ATR inhibitors are synthetic lethal with PBRM1 deficiency, providing a basis for using these inhibitors in PBRM1-defective cancers.

CANCER RESEARCH (2021)

Review Cell Biology

Histone isoforms and the oncohistone code

Andrew Flaus, Jessica A. Downs, Tom Owen-Hughes

Summary: Recent studies have revealed the potential for missense mutations in histones to act as oncogenic drivers, leading to the term 'oncohistones'. Despite the highly conserved nature of histone proteins, there is heterogeneity among the genes encoding them, raising the question of whether all histone-encoding genes function equally as oncohistones. This review explores the implications of this question and delves into the mechanisms by which oncohistones can exert their effects in chromatin.

CURRENT OPINION IN GENETICS & DEVELOPMENT (2021)

Article Multidisciplinary Sciences

TP53 modulates radiotherapy fraction size sensitivity in normal and malignant cells

Selvakumar Anbalagan, Cecilia Stroem, Jessica A. Downs, Penny A. Jeggo, David McBay, Anna Wilkins, Kai Rothkamm, Kevin J. Harrington, John R. Yarnold, Navita Somaiah

Summary: The study suggests that sensitivity to radiotherapy fraction size is dependent on the presence of wild-type p53 and intact non-homologous end-joining. Cells with WT p53 demonstrate split-dose recovery, while NHEJ-deficient cells lack this recovery ability.

SCIENTIFIC REPORTS (2021)

Article Genetics & Heredity

In silico modeling of the interaction between TEX19 and LIRE1, and analysis of TEX19 gene missense SNPs

Faisal A. Alzahrani, Yousef MohammedRabaa Hawsawi, Hisham N. Altayeb, Naif O. Alsiwiehri, Othman R. Alzahrani, Hanan E. Alatwi, Osama M. Al-Amer, Suliman Alomar, Lamjed Mansour

Summary: This study predicted the interaction between TEX19 and LIRE1, as well as analyzed missense polymorphisms of TEX19 using computational methods. The results identified amino acids that may disturb the binding affinity between TEX19 and LIRE1, suggesting potential implications for therapeutic targets.

MOLECULAR GENETICS & GENOMIC MEDICINE (2021)

Article Multidisciplinary Sciences

Improved RAD51 binders through motif shuffling based on the modularity of BRC repeats

Laurens H. Lindenburg, Teodors Pantelejevs, Fabrice Gielen, Pedro Zuazua-Villar, Maren Butz, Eric Rees, Clemens F. Kaminski, Jessica A. Downs, Marko Hyvonen, Florian Hollfelder

Summary: The study focused on the role of RAD51-interacting modules within BRCA2, creating chimeric repeats to measure binding to RAD51. Surprisingly, certain shuffled module combinations showed stronger binding than natural repeats, with weak correlation to affinities of natural repeats. The strongest chimera, BRC8-2, showed improved binding to RAD51 and functioned in preventing the formation of nuclear RAD51 foci in human cells after ionizing radiation.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Oncology

BARD1 mystery: tumor suppressors are cancer susceptibility genes

Yousef M. Hawsawi, Anwar Shams, Abdulrahman Theyab, Wed A. Abdali, Nahed A. Hussien, Hanan E. Alatwi, Othman R. Alzahrani, Atif Abdulwahab A. Oyouni, Ahmad O. Babalghith, Mousa Alreshidi

Summary: This article reviews the spectrum of full-length BARD1 genes and their different isoforms, highlighting their anticipated associated risk. Additionally, the study emphasizes the role of BARD1 as an oncogene in breast cancer patients and its potential uses as a prognostic/diagnostic biomarker and therapeutic target for cancer susceptibility testing and treatment.

BMC CANCER (2022)

Article Multidisciplinary Sciences

Aneuploidy tolerance caused by BRG1 loss allows chromosome gains and recovery of fitness

Federica Schiavoni, Pedro Zuazua-Villar, Theodoros Roumeliotis, Graeme Benstead-Hume, Mercedes Pardo, Frances M. G. Pearl, Jyoti S. Choudhary, Jessica A. Downs

Summary: Aneuploidy causes a decrease in cellular fitness, but it is commonly found in cancer cells and often associated with aggressive growth, indicating that the impact of aneuploidy on cellular fitness depends on the context. In this study, the loss of the BRG1 subunit of the SWI/SNF chromatin remodeling complex is shown to enable tolerance to aneuploidy. This creates an environment where chromosomal changes can occur without a fitness penalty, allowing adaptation to changing environments. This may play a significant role in the progression of BRG1-deficient cancers.

NATURE COMMUNICATIONS (2022)

Article Cell Biology

PBAF loss leads to DNA damage-induced inflammatory signaling through defective G2/M checkpoint maintenance

Hugang Feng, Karen A. Lane, Theodoros Roumeliotis, Penny A. Jeggo, Navita Somaiah, Jyoti S. Choudhary, Jessica A. Downs

Summary: PBRM1 deficiency is associated with the response to immunotherapy in renal cancer, potentially through DNA damage-induced inflammatory signaling and maintenance of the G2/M checkpoint. The mutational status of PBRM1 can predict the response of renal cancer to immunotherapy.

GENES & DEVELOPMENT (2022)

Article Medicine, General & Internal

Clinical and Serological Findings of COVID-19 Participants in the Region of Makkah, Saudi Arabia

Othman R. Alzahrani, Abdullah D. Alanazi, Lauri Kareinen, Yousef M. Hawsawi, Hani A. Alhadrami, Asim A. Khogeer, Hanan E. Alatwi, Amnah A. Alharbi, Tarja Sironen, Olli Vapalahti, Jussi Hepojoki, Fathiah Zakham

Summary: The annual religious event in Makkah, Saudi Arabia, is the largest in the world. Despite strict measures, the region has the second highest number of new COVID-19 cases in Saudi Arabia. Serological tests can complement molecular testing for diagnostics, but patients' medical history should be considered when interpreting the results.

DIAGNOSTICS (2022)

Article Immunology

In Vitro Evaluation of Leuconostoc mesenteroides Cell-Free-Supernatant GBUT-21 against SARS-CoV-2

Othman R. Alzahrani, Yousef M. Hawsawi, Abdullah D. Alanazi, Hanan E. Alatwi, Irfan A. Rather

Summary: This study is a preliminary investigation of the antiviral properties of postbiotic metabolites derived from Leuconostoc mesenteroides GBUT-21, focusing on their potential biological role in inactivating SARS-CoV-2 and reducing related inflammatory pathways.

VACCINES (2022)

Article Oncology

Antiapoptotic Gene Genotype and Allele Variations and the Risk of Lymphoma

Osama M. Al-Amer, Rashid Mir, Abdullah Hamadi, Mohammed I. Alasseiri, Malik A. Altayar, Waseem AlZamzami, Mamdoh Moawadh, Sael Alatawi, Hanan A. Niaz, Atif Abdulwahab A. Oyouni, Othman R. Alzahrani, Hanan E. Alatwi, Aishah E. Albalawi, Khalaf F. Alsharif, Ashraf Albrakati, Yousef M. Hawsawi

Summary: This case-control study found that lymphoma patients are more likely to have genotypes and allele variations in antiapoptotic genes, except for BCL-2-A alterations. These findings could be used to classify and identify patients at risk of lymphoma in the future.

CANCERS (2023)

Article Oncology

Potential Impact of PI3K-AKT Signaling Pathway Genes, KLF-14, MDM4, miRNAs 27a, miRNA-196a Genetic Alterations in the Predisposition and Progression of Breast Cancer Patients

Othman R. Alzahrani, Rashid Mir, Hanan E. Alatwi, Yousef M. Hawsawi, Amnah A. Alharbi, Abdulrahman H. Alessa, Elham Saleh Albalawi, Imadeldin Elfaki, Yousef Alalawi, Laila Moharam, Sabah H. El-Ghaiesh

Summary: A case-control study in Saudi Arabia revealed a strong association between gene variants of PI3K-AKT signaling pathway, KLF 14-AA, MDM4-GA, miR27a-GG, and miR-196a-CT, with the susceptibility and progression of breast cancer. The study also provided valuable insights into the disease mechanisms through whole-exome sequencing.

CANCERS (2023)

Article Medicine, General & Internal

Identification and Characterization of Novel Mutations in Chronic Kidney Disease (CKD) and Autosomal Dominant Polycystic Kidney Disease (ADPKD) in Saudi Subjects by Whole-Exome Sequencing

Othman R. R. Alzahrani, Hanan E. E. Alatwi, Amnah A. A. Alharbi, Abdulrahman H. H. Alessa, Osama M. M. Al-Amer, Abeer F. R. Alanazi, Anwar M. M. Shams, Esra'a Alomari, Abdallah Y. Y. Naser, Faisal A. A. Alzahrani, Salman Hosawi, Saeed M. M. Alghamdi, Wed A. A. Abdali, Imadeldin Elfaki, Yousef M. M. Hawsawi

Summary: This study investigated the genetic basis of ADPKD development in the Saudi population and identified a common variant in the PKD1 gene as well as two novel variants in the PKD1 and PKD2L2 genes. The study found that these mutations contributed to the development of ADPKD in the Saudi population with a median age of 30 years.

MEDICINA-LITHUANIA (2022)

Review Parasitology

Gastrointestinal manifestations of COVID-19: An updated systematic review

O. R. Alzahrani, A. D. Alanazi, Y. M. Hawsawi, H. E. Alatwi, A. A. Alharbi

Summary: Nausea or vomiting, diarrhea, anorexia, and abdominal pain are the most common gastrointestinal symptoms in COVID-19 patients. Contrary to previous assumptions, gastrointestinal symptoms are also important manifestations of COVID-19 infection.

TROPICAL BIOMEDICINE (2022)

暂无数据